Diabetes
2021 marks the centenary of the discovery of insulin. Since that landmark discovery, huge advances have taken place in our understanding of the pathogenesis of type 1 diabetes and type 2 diabetes, as well as improvements in the treatment of patients with diabetes. This Milestone timeline highlights some of the key advances that have occurred in diabetes research over the past 100 years — from the development of synthetic insulin to new drug classes and technologies for the management of diabetes.
This Milestone is editorially independent, produced with financial support from a third party. About this content.
Coordinating editors:
Claire Greenhill, Nature Reviews Endocrinology
Anna Kriebs, Nature Communications
Deepitha Maennich, Nature Reviews Disease Primers
Kirsty Minton, Nature Reviews Immunology
Jennifer Sargent, Nature Medicine
Shimona Starling, Nature Reviews Endocrinology
Writing editors:
Aline Lueckgen, Nature Communications
Heather Wood, Nature Reviews Neurology
Sarah Lemprière, Nature Reviews Neurology
Jessica McHugh, Nature Reviews Rheumatology
Joanna Clarke, Nature Reviews Rheumatology
Sarah Crunkhorn, Nature Reviews Drug Discovery
Paulina Strzyz, Nature Reviews Molecular Cell Biology
Yvonne Bordon, Nature Reviews Immunology
Megan Cully, Nature Reviews Drug Discovery
Isobel Leake, Nature Reviews
Zoltan Fehervari, Nature Immunology
Anna Melidoni, BMC Endocrine Disorders
Alexandra Flemming, Nature Reviews Immunology
Monica Wang, Nature Reviews Nephrology
Lucy Bird, Nature Reviews Immunology
Milestones advisors:
Amanda Adler, University of Oxford, UK
Frances Ashcroft, University of Oxford, UK
Ellen Blaak, Maastricht University, Netherlands
Jeffrey Bluestone, University of California San Francisco, USA
Susan Bonner-Weir, Joslin Diabetes Center, USA
Antonio Ceriello, IRCCS MultiMedica, Italy
Anne Cooke, University of Cambridge, UK
Melanie Davies, University of Leicester, UK
Marc Donath, University Hospital Basel, Switzerland
Daniel Drucker, University of Toronto, Canada
Philippe Froguel, Imperial College London, UK
Anna Gloyn, Stanford University School of Medicine, USA
Matthias Hebrok, University of California San Francisco, USA
Kevan Herold, Yale University, USA
Kamlesh Khunti, University of Leicester, UK
Amira Klip, The Hospital for Sick Children, Canada
Åke Lernmark, Lund University, Sweden
Carel le Roux, University College Dublin, Ireland
Chantal Mathieu, Katholieke Universiteit Leuven, Belgium
Jean Claude Mbanya, University of Yaoundé I, Cameroon
Viswanathan Mohan, Madras Diabetes Research Foundation, India
Helen Murphy, University of East Anglia, UK
David Nathan, Harvard Medical School, USA
Stephen Rich, University of Virginia, USA
Camillo Ricordi, University of Miami Miller School of Medicine, USA
Bart Roep, City of Hope National Medical Center, USA
Peter Rossing, Steno Diabetes Center Copenhagen, Denmark
Steven Russell, Harvard Medical School, USA
Naveed Sattar, University of Glasgow, UK
